- Home
- BMY vs BAM Comparison
BMY vs BAM Comparison
Compare BMY & BAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMY
- BAM
- Stock Information
- Founded
- BMY 1887
- BAM 2022
- Country
- BMY United States
- BAM United States
- Employees
- BMY N/A
- BAM N/A
- Industry
- BMY Biotechnology: Pharmaceutical Preparations
- BAM
- Sector
- BMY Health Care
- BAM
- Exchange
- BMY Nasdaq
- BAM Nasdaq
- Market Cap
- BMY 99.7B
- BAM 99.5B
- IPO Year
- BMY N/A
- BAM N/A
- Fundamental
- Price
- BMY $45.96
- BAM $61.28
- Analyst Decision
- BMY Hold
- BAM Buy
- Analyst Count
- BMY 15
- BAM 11
- Target Price
- BMY $57.64
- BAM $63.48
- AVG Volume (30 Days)
- BMY 13.6M
- BAM 1.9M
- Earning Date
- BMY 07-31-2025
- BAM 08-06-2025
- Dividend Yield
- BMY 5.40%
- BAM 2.76%
- EPS Growth
- BMY N/A
- BAM 43.42
- EPS
- BMY 2.49
- BAM 1.52
- Revenue
- BMY $47,704,000,000.00
- BAM $4,351,000,000.00
- Revenue This Year
- BMY N/A
- BAM $34.15
- Revenue Next Year
- BMY N/A
- BAM $13.79
- P/E Ratio
- BMY $18.48
- BAM $40.37
- Revenue Growth
- BMY 2.57
- BAM 13.81
- 52 Week Low
- BMY $42.96
- BAM $38.32
- 52 Week High
- BMY $63.33
- BAM $64.10
- Technical
- Relative Strength Index (RSI)
- BMY 47.22
- BAM 55.21
- Support Level
- BMY $44.74
- BAM $60.46
- Resistance Level
- BMY $47.26
- BAM $64.10
- Average True Range (ATR)
- BMY 1.22
- BAM 1.47
- MACD
- BMY -0.12
- BAM -0.23
- Stochastic Oscillator
- BMY 47.47
- BAM 42.80
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About BAM Brookfield Asset Management Inc Limited Voting Shares
Brookfield Asset Management Ltd engages in providing alternative asset management services through an ownership interest in a alternative asset management business. It offers a range of alternative investment products to investors around the world including public and private pension plans, endowments and foundations, sovereign wealth funds, financial institutions, insurance companies, and private wealth investors.